Sars-cov-2, COVID-19 Vaccines, Premature Ncds, Vaccine Hesitancy
Digital Object Identifier (DOI)
According to the WHO, as of January 2023, more than 850 million cases and over 6.6 million deaths from COVID-19 have been reported worldwide. Currently, the death rate has been reduced due to the decreased pathogenicity of new SARS-CoV-2 variants, but the major factor in the reduced death rates is the administration of more than 12.8 billion vaccine doses globally. While the COVID-19 vaccines are saving lives, serious side effects have been reported after vaccinations for several premature non-communicable diseases (NCDs). However, the reported adverse events are low in number. The scientific community must investigate the entire spectrum of COVID-19-vaccine-induced complications so that necessary safety measures can be taken, and current vaccines can be re-engineered to avoid or minimize their side effects. We describe in depth severe adverse events for premature metabolic, mental, and neurological disorders; cardiovascular, renal, and autoimmune diseases, and reproductive health issues detected after COVID-19 vaccinations and whether these are causal or incidental. In any case, it has become clear that the benefits of vaccinations outweigh the risks by a large margin. However, pre-existing conditions in vaccinated individuals need to be taken into account in the prevention and treatment of adverse events.
This work is licensed under a Creative Commons Attribution 4.0 License.
Was this content written or created while at USF?
Citation / Publisher Attribution
Vaccines, v. 11, issue 2, art. 208
Scholar Commons Citation
Hromić-Jahjefendić, Altijana; Barh, Debmalya; Uversky, Vladimir N.; Aljabali, Alaa A. A.; Tambuwala, Murtaza M.; Alzahrani, Fuad M.; Alshammeri, Saleh; and Lundstrom, Kenneth, "Can COVID-19 Vaccines Induce Premature Non-communicable Diseases: Where Are We Heading To?" (2023). Molecular Medicine Faculty Publications. 1033.